Elva Almazan is a Houston, Texas based nurse practitioner. Active license number of Elva Almazan is 1069720 for Family in Texas. Her current practice location is 4501 Groveway Dr, Houston. Patients can reach her at 713-644-1568 or can fax her at 713-644-1864. Elva Almazan is MSN, APRN, FNP-BC and her NPI number (Unique professional ID assigned by NPPES) is 1750053278. Elva Almazan has completed additional training beyond basic nursing education and provides primary health care services in accordance with state nurse practice laws or statutes. NPs are trained to assess patient needs, order and interpret diagnostic and laboratory tests, diagnose disease, formulate and prescribe medications and treatment plans.
Complete Profile:
Elva Almazan speciality, credentials, practice address, contact phone number and fax are as below.
Patients can call on the below given phone number for appointment.
NPI number stands for National Provider Identifier which is a unique 10-digit identification number issued to health care providers in the United States by the Centers for Medicare and Medicaid Services (CMS).
NPI details are as mentioned below.
NPI Number:
1750053278
NPI Enumeration Date:
03 Oct, 2021
NPI Last Update On:
14 Apr, 2022
Medical Licenses:
NPs can have one or more medical licenses for different specialities in the same state or different states. Related medical licenses for Elva Almazan are as mentioned below.
License Number
Specialization
State
Status
1069720
Family
Texas
Primary
899627
Registered Nurse
Texas
Secondary
Business Mailing Address:
Business mailing address can be used for mailing purpose only, for visiting purpose patients need to refer above mentioned address.
Address:
Elva Almazan 12377 Merit Dr Ste 300, Dallas, Texas
Zip:
75251-3126
Phone Number:
972-957-3000
Patients can reach Elva Almazan at 4501 Groveway Dr, Houston, Texas or can call to book an appointment on 713-644-1568.
Comments/ Reviews:
Data of this site is collected from Medicare & Medicaid Services (CMS) and NPPES. Last updated on 09 December, 2024.